SILVERCORP METALS INC (SVM)       3.33  -0.2 (-5.67%)

3.33  -0.2 (-5.67%)

CA82835P1036 - Common Stock - After market: 3.3992 +0.07 (+2.08%)


Fundamental Rating

3

Overall SVM gets a fundamental rating of 3 out of 10. We evaluated SVM against 984 industry peers in the Metals & Mining industry. SVM has a great financial health rating, but its profitability evaluates not so good. SVM is valued expensive and it does not seem to be growing.




Profitability

Profitability Rating

1

The Piotroski-F score of SVM is 5.00. This is a neutral score and indicates average health and profitability for SVM.
SVM has a Return On Assets of 2.70%. This is below the industry average of 7.52%. 84% of the industry peers outperform SVM.

SVM's Return On Equity of 3.78% is worse than the rest of the industry. The industry average Return On Equity is 12.14%. 85% of the industry peers have a better Return On Equity.
SVM's Profit Margin of 8.10% is worse than the rest of the industry. The industry average Profit Margin is 15.70%.
VS Industry

ROA (2.7%) VS Industry: 16% outperformed.

-1,125.21
231.29

ROE (3.78%) VS Industry: 15% outperformed.

0.10
290.68

Profit Margin (8.1%) VS Industry: 26% outperformed.

0.58
1,966.43

Valuation

Valuation Rating

3

When comparing the Enterprise Value to EBITDA ratio of SVM to the average industry ratio of 5.63, SVM is valued rather cheaply.
With a Price/Earnings Ratio of 13.88, SVM is valued correctly.
SVM's Price/Earning Ratio is in line with the industry average which is at 11.65.

With a Forward Price/Earnings Ratio of 19.39, SVM is valued rather expensively.
When comparing the current price to the book value of SVM, we can conclude it is valued correctly. It is trading at 1.27 times its book value.
When comparing the price book ratio of SVM to the average industry price book ratio of 1.68, SVM is valued in line with its industry peers.
VS Industry

Price/Earnings (13.88) VS Industry: 44% outperformed.

763.00
0.02

Price/Book (1.27) VS Industry: 60% outperformed.

499.47
0.03

Enterprise Value/ EBITDA (4) VS Industry: 68% outperformed.

1,162.03
0.79

Growth

Growth Rating

2

When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The Earnings Per Share has been decreasing by -7.59% on average over the past 5 years.
The Earnings Per Share is expected to decrease by -1.07% on average over the next 5 years.
The Revenue has been growing slightly by 5.91% on average over the past 5 years.

Based on estimates for the next 5 years, SVM will show a small growth in Revenue. The Revenue will grow by 2.68% on average per year.
SVM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.11%.
SVM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.52%.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-7.59% 17.23% -11.11% -25.7% -23.05% -7.81% -1.07%
Revenue5.91% 8.52% -18.52% -3.23% -1.72% -0.72% 2.68%

Health

Health Rating

7

A Current Ratio of 4.73 indicates that SVM has no problem at all paying its short term obligations.
The Current Ratio of SVM is much better than the industry average of 2.57.
SVM has a Quick Ratio of 4.56. This indicates that SVM is financially healthy and has no problem in meeting its short term obligations.
When comparing the Quick Ratio to an average industry Quick Ratio of 2.22, SVM is better placed than the average industry peer to meet its short term obligations.

SVM has an Altman-Z score of 3.30. This indicates that SVM is financially healthy and little risk of bankruptcy at the moment.
The Debt to Equity ratio of SVM is in line with the industry averages.
SVM has a Altman-Z score comparable to the industry average, which is at 2.60.
SVM has a Piotroski-F score of 5.00. This indicates an average health and profitability for SVM.
VS Industry

Debt/Equity (0) VS Industry: 50% outperformed.

4.83
0.00

Quick Ratio (4.56) VS Industry: 66% outperformed.

0.00
211.92

Current Ratio (4.73) VS Industry: 66% outperformed.

0.00
211.92

Altman-Z (3.3) VS Industry: 54% outperformed.

-22,403.48
1,955.72

Dividend

Dividend Rating

3

25.32% of the earnings are spent on dividend by SVM. This is a low number and sustainable payout ratio.
SVM has been paying a dividend for over 5 years, so it has already some track record.
SVM has a yearly dividend return of 0.75%, which is pretty low.

Compared to an average industry Dividend Yield of 2.10, SVM's dividend is way lower than its industry peers. On top of this 91% of the companies listed in the same industry pay a better dividend than SVM!
Compared to an average S&P500 Dividend Yield of 2.41, SVM's dividend is way lower than the S&P500 average.
VS Industry

Dividend Yield (0.75%) VS Industry: 9% outperformed.

0.25
24.74

SILVERCORP METALS INC3.33

NYSEARCA:SVM (2/3/2023, 7:09:53 PM)-0.2 (-5.67%)

After market: 3.3992 +0.07 (+2.08%)

Chartmill FA Rating
GICS Sector Materials
GICS IndustryGroup Materials
GICS Industry Metals & Mining
Earnings (Last) 11-03 2022-11-03/bmo Earnings (Next) 02-09 2023-02-09/amc
Inst Owners 25.5% Inst Owner Change -0.19%
Ins Owners N/A Ins Owner Change N/A
Market Cap 587.97M Analysts 80
Price Target 4.01 (20.42%)

Dividend
Industry RankSector Rank
Dividend Yield 0.75%
Dividend Growth(5Y) N/A DP 25.32%
Div Incr Years N/A Div Non Decr Years 1
Ex-Date N/A

Surprises & Revisions
EPS beat(2) 1 Avg EPS beat(2) 3.41%
Min EPS beat(2) -11.99% Max EPS beat(2) 18.81%
EPS beat(4) 1 Avg EPS beat(4) -5.65%
Min EPS beat(4) -19.41% Max EPS beat(4) 18.81%
Revenue beat(2) 1 Avg Revenue beat(2) 0.47%
Min Revenue beat(2) -0.77% Max Revenue beat(2) 1.72%
Revenue beat(4) 2 Avg Revenue beat(4) 0.73%
Min Revenue beat(4) -2.02% Max Revenue beat(4) 3.99%
PT rev (1m) 0.99% PT rev (3m) -3.44%
EPS NQ rev (1m) N/A EPS NQ rev (3m) N/A
EPS NY rev (1m) 0% EPS NY rev (3m) -6.23%
Revenue NQ rev (1m) N/A Revenue NQ rev (3m) N/A
Revenue NY rev (1m) 0% Revenue NY rev (3m) -1.45%

Valuation
Industry RankSector Rank
PE 13.88
Fwd PE 19.39
P/S 2.72
P/FCF 22.5
P/OCF 6.23
P/B 1.27
P/tB 1.27
EV/EBITDA 4
EPS(TTM) 0.24 EY 7.21%
EPS(NY) 0.17 Fwd EY 5.16%
FCF(TTM) 0.15 FCFY 4.44%
OCF(TTM) 0.53 OCFY 16.04%
SpS 1.22 BVpS 2.62
TBVpS 2.62 PEG (NY) N/A
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA 2.7%
ROE 3.78%
ROIC 7.82%
ROICexc 11.73%
ROICexgc 11.73%
OM 27.57%
PM 8.1%
GM 41.01%
ROICexgc(3y) 12.22% ROICexcg growth 3Y -5.16%
ROICexcg growth 5Y -10.85% ROICexc(3y) 12.22%
ROICexc growth 3Y -5.16% ROICexc growth 5Y -10.85%
OM growth 3Y -4% OM growth 5Y -5.56%
PM growth 3Y -15.48% PM growth 5Y -12.06%
GM growth 3Y -2.57% GM growth 5Y -3.5%
F-Score 5 Asset Turnover 0.33

Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Debt/EBITDA 0.01
Cap/Depr 236.82%
Profit Quality 149.45%
Current Ratio 4.73
Quick Ratio 4.56
Altman-Z 3.3
F-Score 5 WACC 11.02%
ROIC/WACC 1.06 Cap/Depr(3y) 209.72%
Cap/Depr(5y) 185.98% Profit Quality(3y) 108.64%
Profit Quality(5y) 100.73%

Growth
EPS 1Y -11.11% EPS 3Y 17.23%
EPS 5Y -7.59% EPS growth Q2Q -50%
EPS Next Y -25.7% EPS Next 2Y -23.05%
EPS Next 3Y -7.81% EPS Next 5Y -1.07%
Revenue growth 1Y -18.52% Revenue growth 3Y 8.52%
Revenue growth 5Y 5.91% Revenue growth Q2Q -55.87%
Revenue Next Year -3.23% Revenue Next 2Y -1.72%
Revenue Next 3Y -0.72% Revenue Next 5Y 2.68%
EBIT growth 1Y -35.19% EBIT growth 3Y 4.18%
EBIT growth 5Y 0.02% EBIT Next Year 6.2%
EBIT Next 3Y 9.24% EBIT Next 5Y 11.3%
FCF growth 1Y -51.69% FCF growth 3Y 3.63%
FCF growth 5Y -2.07% OCF growth 1Y 3.87%
OCF growth 3Y 15.11% OCF growth 5Y 5.96%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA